Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
World Journal of Surgery
Published in: World Journal of Surgery 3/2018

01-03-2018 | Original Scientific Report

Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer

Authors: Ka Wing Ma, Tan To Cheung, Wong Hoi She, Kenneth Siu Ho Chok, Albert Chi Yan Chan, Wing Chiu Dai, Wan Hang Chiu, Chung Mau Lo

Published in: World Journal of Surgery | Issue 3/2018

Login to get access

Abstract

Objectives

Role of 18-FDG PET/CT had been well established in other more prevalent malignancies such as colorectal and lung cancer; however, this is not as well defined in cholangiocarcinoma. Literature focusing on the prognostic values of preoperative PET/CT for resectable cholangiocarcinoma is scarce.

Method

This is a retrospective cohort of 66 consecutive patients who had received curative resection for cholangiocarcinoma from 2010 to 2015. All patients had preoperative 18-FDG PET/CT performed. Accuracy of metastatic lymph node detection of PET/CT and the prognostic value of maximum standard uptake value (SUV-max) was explored.

Results

There were 38 male and 28 female recruited, and the median age was 66. Intrahepatic cholangiocarcinoma (ICC) constituted the majority (59.1%) of the cases, followed by hilar cholangiocarcinoma (22.8%), gallbladder cancer (13.6%) and common bile duct cancer (4.5%). The 3-year disease-free survival (DFS) and overall survival (OS) of the whole population were 27.1 and 39.2%, respectively. The median follow-up duration was 27 months. The accuracy of PET/CT in metastatic lymph node detection was 72.7% (P = 0.005, 95% CI 0.583–0.871) and 81.8% (P = 0.011, 95% CI 0.635–0.990) in whole population and ICC subgroup analysis, respectively. SUV-max was shown by multivariate analysis to be an independent factor for DFS (P = 0.007 OR 1.16, 95% CI 1.04–1.29) and OS (P = 0.012 OR 1.145, 95% CI 1.030–1.273) after resection. SUV-max of 8 was shown to be a discriminant cut-off for poor oncological outcomes in patients with early cholangiocarcinoma (TNM stage I or II) after curative resection (3-year DFS: 21.2 vs. 63.2%, P = 0.004, and 3-year OS: 29 vs. 74% P = 0.048, respectively).

Conclusion

PET/CT is a reliable imaging modality for metastatic lymph node detection in cholangiocarcinoma. Tumour SUV-max is an independent factor for oncological outcomes in patients with resectable disease. For patients who have TNM stage I or II cholangiocarcinoma, tumour SUV-max over 8 is associated with significantly inferior disease-free and overall survival even after curative resection.
Literature
1.
Lim JH (2003) Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. Am J Roentgenol 181(3):819–827CrossRef
2.
3.
Shimada K, Sano T, Nara S, Esaki M, Sakamoto Y, Kosuge T et al (2009) Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement. Surgery 145(4):411–416CrossRefPubMed
4.
Choi S-B, Kim K-S, Choi J-Y, Park S-W, Choi J-S, Lee W-J et al (2009) The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol 16(11):3048CrossRefPubMed
5.
6.
Paik KY, Jung JC, Heo JS, Choi SH, Choi DW, Kim YI (2008) What prognostic factors are important for resected intrahepatic cholangiocarcinoma? J Gastroenterol Hepatol 23(5):766–770CrossRefPubMed
7.
Yi B, Zhang B-H, Zhang Y-J, Jiang X-Q, Zhang B-H, Yu W-L et al (2004) Surgical procedure and prognosis of hilar cholangiocarcinoma. Hepatobiliary Pancreat Dis Int HBPD INT 3(3):453–457PubMed
8.
Huang JL, Biehl TR, Lee FT, Zimmer PW, Ryan JA (2004) Outcomes after resection of cholangiocellular carcinoma. Am J Surg 187(5):612–617CrossRefPubMed
9.
Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H et al (2002) Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 89(12):1525–1531CrossRefPubMed
10.
Heimbach JK, Gores GJ, Haddock MG, Alberts SR, Pedersen R, Kremers W et al (2006) Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation 82(12):1703–1707CrossRefPubMed
11.
Miwa S, Miyagawa S, Kobayashi A, Akahane Y, Nakata T, Mihara M et al (2006) Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery. J Gastroenterol 41(9):893–900CrossRefPubMed
12.
Sirica AE, Dumur CI, Campbell DJ, Almenara JA, Ogunwobi OO, Dewitt JL (2009) Intrahepatic cholangiocarcinoma progression: prognostic factors and basic mechanisms. Clin Gastroenterol Hepatol 7(11):S68–S78CrossRefPubMedPubMedCentral
13.
Kim JY, Kim M-H, Lee TY, Hwang CY, Kim JS, Yun S-C et al (2008) Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging. Am J Gastroenterol 103(5):1145–1151CrossRefPubMed
14.
Moon CM, Bang S, Chung JB, Park SW, Song SY, Yun M et al (2008) Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas. J Gastroenterol Hepatol 23(5):759–765CrossRefPubMed
15.
Kluge R, Schmidt F, Caca K, Barthel H, Hesse S, Georgi P et al (2001) Positron emission tomography with [18F] fluoro-2-deoxy-d-glucose for diagnosis and staging of bile duct cancer. Hepatology (Baltimore, MD) 33(5):1029–1035CrossRef
16.
Park TG, Yu Y-D, Park BJ, Cheon GJ, Oh SY, Kim D-S et al (2014) Implication of lymph node metastasis detected on 18F-FDG PET/CT for surgical planning in patients with peripheral intrahepatic cholangiocarcinoma. Clin Nucl Med 39(1):1–7CrossRefPubMed
17.
Lee EJ, Chang S-H, Lee TY, Yoon SY, Cheon YK, Shim CS et al (2015) Prognostic value of FDG-PET/CT total lesion glycolysis for patients with resectable distal bile duct adenocarcinoma. Anticancer Res 35(12):6985–6991PubMed
18.
Lee Y, Yoo IR, Boo SH, Kim H, Park HL (2017) The role of F-18 FDG PET/CT in intrahepatic cholangiocarcinoma. Nucl Med Mol Imaging 51(1):69–78CrossRefPubMed
19.
Cheung TT, Ho CL, Lo CM, Chen S, Chan SC, Chok KS et al (2013) 11C-acetate and 18F-FDG PET/CT for clinical staging and selection of patients with hepatocellular carcinoma for liver transplantation on the basis of Milan criteria: surgeon’s perspective. J Nucl Med 54(2):192–200CrossRefPubMed
20.
Fan S-T, Lo C-M, Liu C-L, Lam C-M, Yuen W-K, Yeung C et al (1999) Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 229(3):322CrossRefPubMedPubMedCentral
21.
Chan SC, Liu CL, Lo CM, Lam BK, Lee EW, Wong Y et al (2006) Estimating liver weight of adults by body weight and gender. World J Gastroenterol WJG 12(14):2217CrossRefPubMed
22.
Nelson JW, Ghafoori AP, Willett CG, Tyler DS, Pappas TN, Clary BM et al (2009) Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys 73(1):148–153CrossRefPubMed
23.
Nathan H, Pawlik TM, Wolfgang CL, Choti MA, Cameron JL, Schulick RD (2007) Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis. J Gastrointest Surg Off J Soc Surg Aliment Tract 11(11):1488–1496 discussion 96–97 CrossRef
24.
Nguyen KT, Steel J, Vanounou T, Tsung A, Marsh JW, Geller DA et al (2009) Initial presentation and management of hilar and peripheral cholangiocarcinoma: is a node-positive status or potential margin-positive result a contraindication to resection? Ann Surg Oncol 16(12):3308–3315CrossRefPubMedPubMedCentral
25.
de Jong MC, Nathan H, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H et al (2011) Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol Off J Am So Clin Oncol 29(23):3140–3145CrossRef
26.
Farges O, Fuks D, Boleslawski E, Le Treut YP, Castaing D, Laurent A et al (2011) Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group. Ann Surg 254(5):824–829 discussion 30 CrossRefPubMed
27.
28.
Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM (2014) Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg 149(6):565–574CrossRefPubMed
29.
Sur MD, In H, Sharpe SM, Baker MS, Weichselbaum RR, Talamonti MS et al (2015) Defining the benefit of adjuvant therapy following resection for intrahepatic cholangiocarcinoma. Ann Surg Oncol 22(7):2209–2217CrossRefPubMed
30.
Tylski P, Stute S, Grotus N, Doyeux K, Hapdey S, Gardin I et al (2010) Comparative assessment of methods for estimating tumor volume and standardized uptake value in 18F-FDG PET. J Nucl Med 51(2):268–276CrossRefPubMed
31.
Xu H-X, Chen T, Wang W-Q, Wu C-T, Liu C, Long J et al (2014) Metabolic tumour burden assessed by 18F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome after resection. Eur J Nucl Med Mol Imaging 41(6):1093–1102CrossRefPubMed
32.
33.
34.
Adebonojo SA, Bowser AN, Moritz DM, Corcoran PC (1999) Impact of revised stage classification of lung cancer on survival: a military experience. CHEST J 115(6):1507–1513CrossRef
35.
Mountain CF (1997) Revisions in the international system for staging lung cancer. Chest 111(6):1710–1717CrossRefPubMed
Metadata
Title
Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer
Authors
Ka Wing Ma
Tan To Cheung
Wong Hoi She
Kenneth Siu Ho Chok
Albert Chi Yan Chan
Wing Chiu Dai
Wan Hang Chiu
Chung Mau Lo
Publication date
01-03-2018
Publisher
Springer International Publishing
Published in
World Journal of Surgery / Issue 3/2018
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-017-4192-3

Other articles of this Issue 3/2018

World Journal of Surgery 3/2018 Go to the issue

Original Scientific Report

Mortality and Morbidity After Hartmann’s Procedure Versus Primary Anastomosis Without a Diverting Stoma for Colorectal Perforation: A Nationwide Observational Study

Original Scientific Report

A Systematic Review and Meta-analysis of Timing and Outcome of Intestinal Failure Surgery in Patients with Enteric Fistula

Original Scientific Report

Implications of Intrahepatic Cholangiocarcinoma Etiology on Recurrence and Prognosis after Curative-Intent Resection: a Multi-Institutional Study

Original Scientific Report

Early Versus Delayed Source Control in Open Abdomen Management for Severe Intra-abdominal Infections: A Retrospective Analysis on 111 Cases

Original Scientific Report

A Clinical Scoring System to Predict the Clinical Sequelae of Computed Tomography Diagnosed Intussusception

Original Scientific Report

Recovery of Voice After Reconstruction of the Recurrent Laryngeal Nerve and Adjuvant Nimodipine